Philip Morris said it expects to record a loss on the sale of its inhaled-therapeutics unit to Molex Asia Holdings as it retools its pharmaceutical business.
Related Posts
Ubisoft Investor Calls For Videogame Maker to Go Private
Shares of Ubisoft Entertainment plunged after a minority investor called for the maker of the Assassin’s Creed videogame franchise to go private and install a […]
Energy & Utilities Roundup: Market Talk
Read about Suncor Energy, energy prices and more in the latest Market Talks covering Energy and Utilities.
Campbell’s CEO Trades Soup and Snacks for the NFL
Mark Clouse will join the Washington Commanders as president early next year after more than five years as the food-company’s boss